Literature DB >> 19115269

Insulin induces the low density lipoprotein receptor-related protein 1 (LRP1) degradation by the proteasomal system in J774 macrophage-derived cells.

Danilo G Ceschin1, María C Sánchez, Gustavo A Chiabrando.   

Abstract

Low-density lipoprotein receptor-related protein 1 (LRP1) is an endocytic receptor, which binds and internalizes diverse ligands such as activated alpha(2)-macroglobulin (alpha(2)M*). LRP1 promotes intracellular signaling, which downstream mediates cellular proliferation and migration of different types of cells, including macrophages. Unlike the LDL receptor, LRP1 expression is not sensitive to cellular cholesterol levels but appears to be responsive to insulin. It has been previously demonstrated that insulin increases the cell surface presentation of LRP1 in adipocytes and hepatocytes, which is mediated by the intracellular PI(3)K/Akt signaling activation. The LRP1 protein distribution is similar to other insulin-regulated cell surface proteins, including transferring receptor (Tfr). However, in macrophages, the insulin effect on the LRP1 distribution and expression is not well characterized. Considering that macrophages play a central role in the pathogenesis of atherosclerosis, herein we evaluate the effect of insulin on the cellular expression of LRP1 in J774 macrophages-derived cells using Western blot and immunofluorescence microscopy. Our data demonstrate that insulin induces a significant decrease in the LRP1 protein content, without changing the specific mRNA level of this receptor. Moreover, insulin specifically affected the protein expression of LRP1 but not Tfr. The insulin-induced protein degradation of LRP1 in J774 cells was mediated by the activation of the PI(3)K/Akt pathway and proteasomal system by an enhanced ubiquitin-receptor conjugation. The decreased content of LRP1 induced by insulin affected the cellular internalization of alpha(2)M*. Thus, we propose that the protein degradation of LRP-1 induced by insulin in macrophages could have important effects on the pathogenesis of atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19115269     DOI: 10.1002/jcb.22014

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  13 in total

1.  Cell cholesterol modulates metalloproteinase-dependent shedding of low-density lipoprotein receptor-related protein-1 (LRP-1) and clearance function.

Authors:  Charlotte Selvais; Ludovic D'Auria; Donatienne Tyteca; Gwenn Perrot; Pascale Lemoine; Linda Troeberg; Stéphane Dedieu; Agnès Noël; Hideaki Nagase; Patrick Henriet; Pierre J Courtoy; Etienne Marbaix; Hervé Emonard
Journal:  FASEB J       Date:  2011-04-25       Impact factor: 5.191

Review 2.  LDL receptor-related protein-1: a regulator of inflammation in atherosclerosis, cancer, and injury to the nervous system.

Authors:  Steven L Gonias; W Marie Campana
Journal:  Am J Pathol       Date:  2013-10-12       Impact factor: 4.307

Review 3.  Low-density lipoprotein receptor-related protein 1: a physiological Aβ homeostatic mechanism with multiple therapeutic opportunities.

Authors:  Abhay P Sagare; Rashid Deane; Berislav V Zlokovic
Journal:  Pharmacol Ther       Date:  2012-07-20       Impact factor: 12.310

Review 4.  Neurovascular defects and faulty amyloid-β vascular clearance in Alzheimer's disease.

Authors:  Abhay P Sagare; Robert D Bell; Berislav V Zlokovic
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

5.  Platelet factor 4 regulates megakaryopoiesis through low-density lipoprotein receptor-related protein 1 (LRP1) on megakaryocytes.

Authors:  Michele P Lambert; Yuhuan Wang; Khalil H Bdeir; Yvonne Nguyen; M Anna Kowalska; Mortimer Poncz
Journal:  Blood       Date:  2009-07-15       Impact factor: 22.113

6.  Myeloid cell receptor LRP1/CD91 regulates monocyte recruitment and angiogenesis in tumors.

Authors:  Nicole D Staudt; Minji Jo; Jingjing Hu; Jeanne M Bristow; Donald P Pizzo; Alban Gaultier; Scott R VandenBerg; Steven L Gonias
Journal:  Cancer Res       Date:  2013-04-30       Impact factor: 12.701

7.  Molecular targets for 17α-ethynyl-5-androstene-3β,7β,17β-triol, an anti-inflammatory agent derived from the human metabolome.

Authors:  Christopher L Reading; James M Frincke; Steven K White
Journal:  PLoS One       Date:  2012-02-24       Impact factor: 3.240

Review 8.  Stress hyperglycemia, insulin treatment, and innate immune cells.

Authors:  Fangming Xiu; Mile Stanojcic; Li Diao; Marc G Jeschke
Journal:  Int J Endocrinol       Date:  2014-05-08       Impact factor: 3.257

9.  Soluble LRP1 is an independent biomarker of epicardial fat volume in patients with type 1 diabetes mellitus.

Authors:  David de Gonzalo-Calvo; Cristina Colom; David Vilades; Andrea Rivas-Urbina; Abdel-Hakim Moustafa; Montserrat Pérez-Cuellar; Jose Luis Sánchez-Quesada; Antonio Pérez; Vicenta LLorente-Cortes
Journal:  Sci Rep       Date:  2018-01-18       Impact factor: 4.379

10.  p53 Regulates the Expression of LRP1 and Apoptosis through a Stress Intensity-Dependent MicroRNA Feedback Loop.

Authors:  Patrick L Leslie; Derek A Franklin; Yong Liu; Yanping Zhang
Journal:  Cell Rep       Date:  2018-08-07       Impact factor: 9.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.